Turnstone Biologics Ownership | Who Owns Turnstone Biologics?
Turnstone Biologics Ownership Summary
Turnstone Biologics is owned by 36.45% institutional investors, 7.70% insiders, and 55.85% retail investors. Orbimed advisors is the largest institutional shareholder, holding 13.39% of TSBX shares.
TSBX Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Turnstone Biologics | 36.45% | 7.70% | 55.85% |
Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Orbimed advisors | 3.10M | 13.39% | $1.11M |
Bml capital management | 1.10M | 4.77% | $396.12K |
Takeda pharmaceutical | 895.82K | 3.87% | $321.60K |
Point72 asset management | 816.92K | 3.53% | $293.27K |
72 investment | 549.98K | 2.38% | $225.49K |
Deltec asset management | 106.06K | 0.46% | $38.07K |
Hrt financial lp | 55.86K | 0.24% | $20.00K |
Gts securities | 45.16K | 0.20% | $16.21K |
Millennium management | 38.86K | 0.17% | $15.93K |
Xtx topco | 37.79K | 0.16% | $13.56K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Takeda pharmaceutical | 895.82K | 1.64% | $321.60K |
72 investment | 549.98K | 0.63% | $225.49K |
Bml capital management | 1.10M | 0.30% | $396.12K |
Orbimed advisors | 3.10M | 0.03% | $1.11M |
Deltec asset management | 106.06K | 0.01% | $38.07K |
Gts securities | 45.16K | 0.00% | $16.21K |
Xtx topco | 37.79K | 0.00% | $13.56K |
Point72 asset management | 816.92K | 0.00% | $293.27K |
Hrt financial lp | 55.86K | 0.00% | $20.00K |
Pfm health sciences, lp | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Deltec asset management | 106.06K | 0.01% | 106.06K |
Gts securities | 45.16K | 0.00% | 45.16K |
Hrt financial lp | 55.86K | 0.00% | 43.78K |
Xtx topco | 37.79K | 0.00% | 2.04K |
Orbimed advisors | 3.10M | 0.03% | - |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Pfm health sciences, lp | - | - | -932.35K |
Sectoral asset management | - | - | -517.65K |
Fil | - | - | -192.66K |
Point72 asset management | 816.92K | 0.00% | -62.01K |
Citigroup | - | - | -61.41K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Deltec asset management | 106.06K | 0.01% | 106.06K | $38.07K |
Gts securities | 45.16K | 0.00% | 45.16K | $16.21K |
Sold Out
Holder | Change |
---|---|
Virtu financial | -14.81K |
Nordwand advisors | -20.00K |
Goldman sachs group | -20.52K |
Citigroup | -61.41K |
Fil | -192.66K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 23 | - | 8,434,667 | -18.84% | 36 | 1.81% | 7 | 16.67% | 8 | -20.00% |
Mar 31, 2025 | 4 | -85.71% | 4,620,451 | -58.36% | 19 | 0.86% | - | -100.00% | 1 | -83.33% |
Dec 31, 2024 | 28 | 16.67% | 11,096,493 | -3.03% | 48 | 1.95% | 13 | 85.71% | 6 | -40.00% |
Sep 30, 2024 | 24 | -45.45% | 11,443,046 | -9.91% | 49 | 1.63% | 7 | -73.08% | 10 | -16.67% |
Jun 30, 2024 | 44 | 10.00% | 12,701,707 | -4.85% | 55 | 1.64% | 26 | 8.33% | 12 | 50.00% |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jul 25, 2023 | Versant Ventures V, LLC | - | Buy | $2.37M |
Jul 25, 2023 | Versant Ventures V, LLC | - | Buy | $180.34K |
Jul 25, 2023 | Versant Ventures V, LLC | - | Buy | $78.90K |
Jul 25, 2023 | Versant Ventures V, LLC | - | Buy | $71.27K |
Jul 20, 2023 | ORBIMED ADVISORS LLC | Buy | $5.00M |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q3 | - | - |
2024 Q2 | - | - |
2024 Q1 | - | - |
2023 Q4 | - | - |
2023 Q3 | 5 | - |
TSBX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools